The effects of ICS 205–930, A 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion
- 1 August 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 127 (3) , 211-218
- https://doi.org/10.1016/0014-2999(86)90366-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Do Alterations in Prostanoid or Catecholamine Release Influence the Antiarrhythmic Activity of Nicergoline?Journal of Cardiovascular Pharmacology, 1986
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- Antiarrhythmic and Electrophysiological Effects of ICS 205-930, an Antagonist of 5-Hydroxytryptamine at Peripheral ReceptorsJournal of Cardiovascular Pharmacology, 1985
- Inhibition of noradrenaline (NA)-induced cardiac arrhythmias in the rat by ICS 205–930Journal of Molecular and Cellular Cardiology, 1984
- Further evidence that thromboxane exacerbates arrhythmias: Effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhoundsJournal of Molecular and Cellular Cardiology, 1984
- Nifedipine Reduces Arrhythmias But Does Not Alter Prostanoid Release During Coronary Artery Occlusion and Reperfusion in Anaesthetised GreyhoundsJournal of Cardiovascular Pharmacology, 1983
- Coronary artery spasm in intact dogs induced by potassium and serotonin.Circulation Research, 1983
- The interactions of platelet-derived mediators on isolated canine coronary arteriesEuropean Journal of Pharmacology, 1982
- Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmiasNature, 1981
- Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole rangeLife Sciences, 1976